A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 8,150 shares of TECH stock, worth $601,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,150
Previous 9,062 10.06%
Holding current value
$601,388
Previous $649,000 0.31%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$70.96 - $82.35 $64,715 - $75,103
-912 Reduced 10.06%
8,150 $651,000
Q2 2024

Jul 19, 2024

BUY
$62.12 - $84.15 $6,522 - $8,835
105 Added 1.17%
9,062 $649,000
Q1 2024

Apr 22, 2024

BUY
$65.98 - $77.09 $327,326 - $382,443
4,961 Added 124.15%
8,957 $630,000
Q4 2023

Jan 16, 2024

SELL
$52.83 - $78.22 $18,913 - $28,002
-358 Reduced 8.22%
3,996 $308,000
Q3 2023

Oct 24, 2023

SELL
$67.52 - $89.42 $4,321 - $5,722
-64 Reduced 1.45%
4,354 $296,000
Q2 2023

Jul 25, 2023

BUY
$73.76 - $85.98 $3,319 - $3,869
45 Added 1.03%
4,418 $360,000
Q1 2023

Apr 14, 2023

BUY
$71.62 - $86.62 $20,483 - $24,773
286 Added 7.0%
4,373 $324,000
Q4 2022

Feb 08, 2023

BUY
$80.67 - $352.29 $249,754 - $1.09 Million
3,096 Added 312.41%
4,087 $338,000
Q3 2022

Oct 25, 2022

BUY
$282.54 - $391.85 $8,193 - $11,363
29 Added 3.01%
991 $281,000
Q2 2022

Aug 12, 2022

BUY
$322.67 - $449.65 $44,528 - $62,051
138 Added 16.75%
962 $333,000
Q1 2022

May 11, 2022

SELL
$353.85 - $487.79 $32,908 - $45,364
-93 Reduced 10.14%
824 $357,000
Q4 2021

Feb 08, 2022

SELL
$456.15 - $525.06 $978,897 - $1.13 Million
-2,146 Reduced 70.06%
917 $474,000
Q3 2021

Nov 02, 2021

BUY
$444.87 - $538.88 $751,385 - $910,168
1,689 Added 122.93%
3,063 $1.48 Million
Q2 2021

Aug 11, 2021

BUY
$387.35 - $450.26 $47,644 - $55,381
123 Added 9.83%
1,374 $619,000
Q1 2021

May 14, 2021

BUY
$314.62 - $411.0 $48,136 - $62,883
153 Added 13.93%
1,251 $478,000
Q4 2020

Feb 12, 2021

SELL
$246.9 - $321.87 $923,899 - $1.2 Million
-3,742 Reduced 77.31%
1,098 $349,000
Q3 2020

Nov 04, 2020

BUY
$232.22 - $282.96 $594,947 - $724,943
2,562 Added 112.47%
4,840 $1.2 Million
Q2 2020

Jul 17, 2020

BUY
$185.43 - $279.56 $422,409 - $636,837
2,278 New
2,278 $602,000
Q1 2020

Apr 21, 2020

SELL
$161.17 - $221.51 $172,451 - $237,015
-1,070 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$189.68 - $222.09 $21,244 - $24,874
-112 Reduced 9.48%
1,070 $235,000
Q3 2019

Nov 07, 2019

BUY
$183.56 - $216.72 $216,967 - $256,163
1,182 New
1,182 $231,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.89B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.